Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Commerce

TENTH MEETING

2019-2020 Regular Session - Wednesday, February 20, 2019

STATE OF MINNESOTA TENTH MEETING
HOUSE OF REPRESENTATIVES NINETY-FIRST SESSION

COMMERCE COMMITTEE

MINUTES

Representative Laurie Halverson, Chair of the Commerce Committee, called the meeting to order at 2:33PM on February 20th, 2019, in the Basement Hearing Room of the State Office Building.

The Committee Legislative Assistant noted the roll.

Members present:

HALVERSON, Laurie, Chair
STEPHENSON, Zack, Vice Chair
O’DRISCOLL, Tim, GOP Lead
CARLSON, Andrew
DAVIDS, Gregory
DEHN, Raymond
ELKINS, Steve
GAROFALO, Pat
HALEY, Barb
HOWARD, Michael
KOTYZA-WITTHUHN, Carlie
KRESHA, Ron
LESCH, John
LISLEGARD, Dave
MAHONEY, Tim
O’NEILL, Marion
RICHARDSON, Ruth
TABKE, Brad
THEIS, Tama

Members excused:

SWEDZINSKI, Chris

A quorum was present.

Representative Stephenson moved to approve the minutes of February 19th, 2019. THE MOTION PREVAILED.


HF4 (Lesch)
Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.

Representative Lesch moved that HF4 be re-referred to Judiciary, and moves the HF0004A2 (Lesch) amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Davids moves to make an oral amendment to HF0004A2 amendment for:

Page 1, after line 23 insert:

Page 8, delete lines 22-25.

THE MOTION PREVAILED AND THE AMENDEMDMENT TO THE AMENDMENT WAS ADOPTED.

Testifiers In Support of HF4
Stephen Schondelmeyer, PharmD, PhD, Professor and Head, Department of Pharmaceutical Care & Health Systems, University of Minnesota
Will Philips, State Director, AARP
Allen Gilbert, former Solicitor General, State of Minnesota
Rick Varco, Political Director, SEIU HCMN
Cody Weiberg, Executive Director of the Board of Pharmacy

Representative Stephenson chaired the committee at 2:57PM.

Representative Lesch renewed the motion that HF4, as amended, be re-referred to Judiciary. THE MOTION PREVAILED.

The meeting was adjourned at 4:05PM.







Representative Laurie Halverson, Chair




Aimee Vue,
Committee Legislative Assistant






More Info On This Meeting..
Bills Added:
  • HF4 (Lesch) - Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; civil penalties imposed; and money appropriated.
Documents:

HF 4 (Lesch) Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; and civil penalties imposed.

If you would like to testify, please email the committee administrator: Laura.Taken-Holtze@house.mn